Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

Advances in DNA sequencing have made genetic testing fast and affordable, but limitations of testing processes are impeding realisation of patient benefits. Ovarian cancer exemplifies the potential value of genetic testing and the shortcomings of current pathways to access testing. Approximately 15%...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: George, A, Riddell, D, Seal, S, Talukdar, S, Mahamdallie, S, Ruark, E, Cloke, V, Slade, I, Kemp, Z, Gore, M, Strydom, A, Banerjee, S, Hanson, H, Rahman, N
التنسيق: Journal article
اللغة:English
منشور في: Nature Research 2016

مواد مشابهة

مواد مشابهة